Skip to main content
Erschienen in: Strahlentherapie und Onkologie 1/2024

16.11.2023 | Original Article

Comparison of patient setup accuracy for optical surface-guided and X-ray-guided imaging with respect to the impact on intracranial stereotactic radiotherapy

verfasst von: Michael Schöpe, Jacob Sahlmann, Stefan Jaschik, Anne Findeisen, Gunther Klautke

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The objective of this work is to estimate the patient positioning accuracy of a surface-guided radiation therapy (SGRT) system using an optical surface scanner compared to an X‑ray-based imaging system (IGRT) with respect to their impact on intracranial stereotactic radiotherapy (SRT) and intracranial stereotactic radiosurgery (SRS).

Methods

Patient positioning data, both acquired with SGRT and IGRT systems at the same linacs, serve as a basis for determination of positioning accuracy. A total of 35 patients with two different open face masks (578 datasets) were positioned using X‑ray stereoscopic imaging and the patient position inside the open face mask was recorded using SGRT. The measurement accuracy of the SGRT system (in a “standard” and an SRS mode with higher resolution) was evaluated using both IGRT and SGRT patient positioning datasets taking into account the measurement errors of the X‑ray system. Based on these clinically measured datasets, the positioning accuracy was estimated using Monte Carlo (MC) simulations. The relevant evaluation criterion, as standard of practice in cranial SRT, was the 95th percentile.

Results

The interfractional measurement displacement vector of the SGRT system, σSGRT, in high resolution mode was estimated at 2.5 mm (68th percentile) and 5 mm (95th percentile). If the standard resolution was used, σSGRT increased by about 20%. The standard deviation of the axis-related σSGRT of the SGRT system ranged between 1.5 and 1.8 mm interfractionally and 0.5 and 1.0 mm intrafractionally. The magnitude of σSGRT is mainly due to the principle of patient surface scanning and not due to technical limitations or vendor-specific issues in software or hardware. Based on the resulting σSGRT, MC simulations served as a measure for the positioning accuracy for non-coplanar couch rotations. If an SGRT system is used as the only patient positioning device in non-coplanar fields, interfractional positioning errors of up to 6 mm and intrafractional errors of up to 5 mm cannot be ruled out. In contrast, MC simulations resulted in a positioning error of 1.6 mm (95th percentile) using the IGRT system. The cause of positioning errors in the SGRT system is mainly a change in the facial surface relative to a defined point in the brain.

Conclusion

In order to achieve the necessary geometric accuracy in cranial stereotactic radiotherapy, use of an X‑ray-based IGRT system, especially when treating with non-coplanar couch angles, is highly recommended.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
6.
Zurück zum Zitat Li S, Geng J, Williams J et al. (2000) A novel 3D-video-based refixation technique for fractionated stereotactic radiotherapy. In: Proceedings of the 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (Cat. No.00CH37143). IEEE, p 2693 Li S, Geng J, Williams J et al. (2000) A novel 3D-video-based refixation technique for fractionated stereotactic radiotherapy. In: Proceedings of the 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (Cat. No.00CH37143). IEEE, p 2693
27.
Zurück zum Zitat Perks JR, Jalali R, Cosgrove VP et al. (1999) Optimization of stereotactically-guided conformal treatment planning of sellar and parasellar tumors, based on normal brain dose volume histograms. International Journal of Radiation Oncology*Biology*Physics 45(2): 507–513. https://doi.org/10.1016/S0360-3016(99)00156‑X Perks JR, Jalali R, Cosgrove VP et al. (1999) Optimization of stereotactically-guided conformal treatment planning of sellar and parasellar tumors, based on normal brain dose volume histograms. International Journal of Radiation Oncology*Biology*Physics 45(2): 507–513. https://​doi.​org/​10.​1016/​S0360-3016(99)00156‑X
31.
32.
Zurück zum Zitat Verellen D, Linthout N, Bel A et al. (1999) Assessment of the uncertainties in dose delivery of a commercial system for linac-based stereotactic radiosurgery. International Journal of Radiation Oncology*Biology*Physics 44(2): 421–433. https://doi.org/10.1016/S0360-3016(99)00020‑6 Verellen D, Linthout N, Bel A et al. (1999) Assessment of the uncertainties in dose delivery of a commercial system for linac-based stereotactic radiosurgery. International Journal of Radiation Oncology*Biology*Physics 44(2): 421–433. https://​doi.​org/​10.​1016/​S0360-3016(99)00020‑6
Metadaten
Titel
Comparison of patient setup accuracy for optical surface-guided and X-ray-guided imaging with respect to the impact on intracranial stereotactic radiotherapy
verfasst von
Michael Schöpe
Jacob Sahlmann
Stefan Jaschik
Anne Findeisen
Gunther Klautke
Publikationsdatum
16.11.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 1/2024
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-023-02170-x

Weitere Artikel der Ausgabe 1/2024

Strahlentherapie und Onkologie 1/2024 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.